SCHEMBL20469751

SCHEMBL20469751

CC(=O)Nc1ccc2oc(-c3ccnc(C(=O)N4CCN([C@H](c5ccccc5)c5n[nH]c(C)n5)CC4)c3)nc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.49
▸ SMN1; SMN2 Q16637 6/20 0.49
▸ NPC1 O15118 6/20 0.49
▸ RAB9A P51151 6/20 0.49
▸ KDM4E B2RXH2 5/20 0.49
▸ POLB P06746 5/20 0.49
▸ UTRN P46939 2/20 0.46
▸ CASP3 P42574 2/20 0.41
▸ SENP7 Q9BQF6 2/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41
▸ MAPT P10636 5/20 0.41
▸ HPGD P15428 5/20 0.41
▸ HSD17B10 Q99714 4/20 0.41
▸ TP53 P04637 2/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41
▸ RELA Q04206 1/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20469796 1.00 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL23542058 1.00 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL20469791 0.90 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL20469718 0.86 CETP (0.43) ALDH1A1SMN1; SMN2KDM4EMAPTHPGD
SCHEMBL29572967 0.86 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL20469752 0.86 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL20469756 0.85 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL23033529 0.84 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL23012142 0.84 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL23033455 0.84 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11040963-B2 Piperazine derivatives for influenza virus inhibitions JANSSEN VACCINES & PREVENTION B.V. (NL) 2021-06-22 — — US disclosed
WO-2018141854-A1 PIPERAZINE DERIVATIVES FOR INFLUENZA VIRUS INHIBITION JANSSEN VACCINES & PREVENTION B.V. (NL) 2018-08-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11040963-B2 Piperazine derivatives for influenza virus inhibitions HAVCR2, BAZ2A, MAVS ALDH1A1 631/4885SMN1; SMN2 4850/4885NPC1 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback